OOIR: Observatory of International Research

Papers

(The median citation count of Circulation-Genomic and Precision Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association	196
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework	108
Alcohol Consumption and Cardiovascular Disease	97
Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes	79
Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction	69
Variant Interpretation for Dilated Cardiomyopathy	63
Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels	60
Polygenic Hyperlipidemias and Coronary Artery Disease Risk	57
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association	57
Implications of Genetic Testing in Dilated Cardiomyopathy	52
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart As	51
Metabolic Age Based on the BBMRI-NL ¹ H-NMR Metabolomics Repository as Biomarker of Age-related Disease	46
How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study	45
Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association	43
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy	43
HeterozygousABCG5Gene Deficiency and Risk of Coronary Artery Disease	42
Spontaneous Coronary Artery Dissection	42
Transethnic Meta-Analysis of Genome-Wide Association Studies Identifies Three New Loci and Characterizes Population-Specific Differences for Coronary Artery Disease	42
Whole Blood DNA Methylation Signatures of Diet Are Associated With Cardiovascular Disease Risk Factors and All-Cause Mortality	40
Multiple Somatic Mutations for Clonal Hematopoiesis Are Associated With Increased Mortality in Patients With Chronic Heart Failure	39
SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families	39
Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia	33
Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy	33
Reevaluation of the South Asian MYBPC3 ^Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy	30
Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics	28

De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease	28
Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis	27
Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease	27
Clinical Profile of Cardiac Involvement in Danon Disease	27
Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension	25
Genome-Wide Association Study of Peripheral Artery Disease	24
Inherited Cardiomyopathies Revealed by Clinically Suspected Myocarditis	24
Transethnic Transferability of a Genome-Wide Polygenic Score for Coronary Artery Disease	23
Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association	23
Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies	23
Genetic Basis of Left Ventricular Noncompaction	22
Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review	21
Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy	21
Corrected QT Interval–Polygenic Risk Score and Its Contribution to Type 1, Type 2, and Type 3 Long-QT Syndrome in Probands and Genotype-Positive Family Members	21
Sexual Differences in Genetic Predisposition of Coronary Artery Disease	21
Cadherin 2-Related Arrhythmogenic Cardiomyopathy	20
Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes	20
Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis	20
Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia	19
Combining Clinical and Polygenic Risk Improves Stroke Prediction Among Individuals With Atrial Fibrillation	19
Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in MYBPC3	18
Categorized Genetic Analysis in Childhood-Onset Cardiomyopathy	18
Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population	18
Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women	18
Polygenic Risk Score for Coronary Artery Disease Improves the Prediction of Early-Onset Myocardial Infarction and Mortality in Men	17
Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in TNNI3 and TNNT2 That Are Common in Chinese Patients	17
Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry	17
Predictive Accuracy of a Polygenic Risk Score for Postoperative Atrial Fibrillation After Cardiac Surgery	16
Genetic Risk Scores for Complex Disease Traits in Youth	16
Concordance of a High Polygenic Score Among Relatives	16
Contribution of Noncanonical Splice Variants toTTNTruncating Variant Cardiomyopathy	15
Cardiac Imaging of Aortic Valve Area From 34 287 UK Biobank Participants Reveals Novel Genetic Associations and Shared Genetic Comorbidity With Multiple Disease Phenotypes	15
Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation	15
Exome Sequencing and Congenital Heart Disease in Sub-Saharan Africa	15
The Propagation of Racial Disparities in Cardiovascular Genomics Research	15
Exome Sequencing Highlights a Potential Role for Concealed Cardiomyopathies in Youthful Sudden Cardiac Death	15
Exploring the Genetic Architecture of Spontaneous Coronary Artery Dissection Using Whole-Genome Sequencing	14
Comprehensive Investigation of Circulating Biomarkers and Their Causal Role in Atherosclerosis-Related Risk Factors and Clinical Events	14
Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria	13
Provocation Testing and Therapeutic Response in a Newly Described Channelopathy: RyR2 Calcium Release Deficiency Syndrome	13
Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older	13
Genotype-Guided Dosing of Warfarin in Chinese Adults	13
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Myocarditis	13
Conserved Role of the Large Conductance Calcium-Activated Potassium Channel, K _Ca 1.1, in Sinus Node Function and Arrhythmia Risk	13
Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants	12
Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot	12
Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults	12
Genetically Determined Birthweight Associates With Atrial Fibrillation	12
Recent Advances on the Genetics of Spontaneous Coronary Artery Dissection	12
Predictive Accuracy of a Clinical and Genetic Risk Model for Atrial Fibrillation	12

Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated With Brugada Syndrome	12
Evaluation of Clinical Practices Related to Variants of Uncertain Significance Results in Inherited Cardiac Arrhythmia and Inherited Cardiomyopathy Genes	11
CELSR1 Risk Alleles in Familial Bicuspid Aortic Valve and Hypoplastic Left Heart Syndrome	11
Epigenetic Analyses of Human Left Atrial Tissue Identifies Gene Networks Underlying Atrial Fibrillation	11
Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction	11
Role of Rare and Low-Frequency Variants in Gene-Alcohol Interactions on Plasma Lipid Levels	11
Clinical Utility of a Phenotype-Enhanced MYH7 -Specific Variant Classification Framework in Hypertrophic Cardiomyopathy Genetic Testing	11
Arrhythmic Phenotypes Are a Defining Feature of Dilated Cardiomyopathy-Associated SCN5A Variants: A Systematic Review	11
Genetically Determined Serum Calcium Levels and Markers of Ventricular Repolarization: A Mendelian Randomization Study in the UK Biobank	11
Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic LPA Gene Expression Levels With Cardiovascular Outcomes: Mendelian Rand	11
Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions	11
Moving Genomics to Routine Care	11
Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention	11
Characteristics of Cardiac Phenotype in Prenatal Familial Cases With NONO Mutations	11
FADS1 (Fatty Acid Desaturase 1) Genotype Associates With Aortic Valve FADS mRNA Expression, Fatty Acid Content and Calcification	10
Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial	10
Lifelong Reduction in LDL (Low-Density Lipoprotein) Cholesterol due to a Gain-of-Function Mutation in LDLR	10
Rare, Damaging DNA Variants in CORIN and Risk of Coronary Artery Disease: Insights From Functional Genomics and Large-Scale Sequencing Analyses	10
Meta-Analysis of 26 638 Individuals Identifies Two Genetic Loci Associated With Left Ventricular Ejection Fraction	10
Integrative Prioritization of Causal Genes for Coronary Artery Disease	10
Clinical Impact of Secondary Risk Factors in TTN -Mediated Dilated Cardiomyopathy	10
Genetic Basis of Childhood Cardiomyopathy	10
Revisiting the Diagnostic Yield of Hypertrophic Cardiomyopathy Genetic Testing	10
LMNA Missense Mutation Causes Nonsense-Mediated mRNA Decay and Severe Dilated Cardiomyopathy	10
Promise and Peril of Population Genomics for the Development of Genome-First Approaches in Mendelian Cardiovascular Disease	10
Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for KCND3 -Encoded Kv4.3 Gain-of-Function-Associated J-Wave Syndromes	10
SOS1 Gain-of-Function Variants in Dilated Cardiomyopathy	10
Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants	10
Molecular Management of Multifocal Atrial Tachycardia in Noonan’s Syndrome With MEK1/2 Inhibitor Trametinib	10
Multiomics Screening Identifies Molecular Biomarkers Causally Associated With the Risk of Coronary Artery Disease	9
Polygenic Risk Score–Enhanced Risk Stratification of Coronary Artery Disease in Patients With Stable Chest Pain	9
Early Lethality Due to a Novel Desmoplakin Variant Causing Infantile Epidermolysis Bullosa Simplex With Fragile Skin, Aplasia Cutis Congenita, and Arrhythmogenic Cardiomyopathy	9
Use of a Polygenic Risk Score Improves Prediction of Myocardial Injury After Non-Cardiac Surgery	9
A Pathogenic Variant inALPK3Is Associated With an Autosomal Dominant Adult-onset Hypertrophic Cardiomyopathy	9
Homozygous SPEG Mutation Is Associated With Isolated Dilated Cardiomyopathy	9
Genetic Predictor to Identify Individuals With High Lipoprotein(a) Concentrations	9
Pathway-Specific Polygenic Risk Scores Identify Obstructive Sleep Apnea–Related Pathways Differentially Moderating Genetic Susceptibility to Coronary Artery Disease	9
Genetic Basis and Prognostic Value of Exercise QT Dynamics	9
Novel Mutation in LOX Associates With a Complex Aneurysmal Vascular and Cardiac Phenotype	8
Genetic Analysis of Patients With Sickle Cell Anemia and Stroke Before 4 Years of Age Suggest an Important Role for Apoliprotein E	8
Familial Hypercholesterolemia in a Healthy Elderly Population	8
Genome-Wide De Novo Variants in Congenital Heart Disease Are Not Associated With Maternal Diabetes or Obesity	8
Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy	8
Mono- and Biallelic Protein-Truncating Variants in Alpha-Actinin 2 Cause Cardiomyopathy Through Distinct Mechanisms	8
Interpretation of Incidental Genetic Findings Localizing to Genes Associated With Cardiac Channelopathies and Cardiomyopathies	8
Current State and Future of Polygenic Risk Scores in Cardiometabolic Disease: A Scoping Review	8
Loss-of-Function FLNC Variants Are Associated With Arrhythmogenic Cardiomyopathy Phenotypes When Identified Through Exome Sequencing of a General Clinical Population	8
Heart Transplantation for TANGO2 -Related Metabolic Encephalopathy and Arrhythmia Syndrome–Associated Cardiomyopathy	8
Novel Gain-of-Function Variant in CACNA1C Associated With Timothy Syndrome, Multiple Accessory Pathways, and Noncompaction Cardiomyopathy	8
Pathogenicity Assignment of Variants in Genes Associated With Cardiac Channelopathies Evolve Toward Diagnostic Uncertainty	8
Clinical Impact of Copy Number Variation on the Genetic Diagnosis of Syndromic Aortopathies	7
Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome	7
Increased Burden of Ion Channel Gene Variants Is Related to Distinct Phenotypes in Pediatric Patients With Left Ventricular Noncompaction	7
Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart Association	7
Steps Toward Minimal Reporting Standards for Lipidomics Mass Spectrometry in Biomedical Research Publications	7
Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Choleste	7
Importance of Dedicated Units for the Management of Patients With Inherited Arrhythmia Syndromes	7
Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis	7
Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes	7
Congenital Heart Defects Due to TAF1 Missense Variants	7
Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands	7
Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults	7
KCNQ1 and Long QT Syndrome in 1/45 Amish	7
Screening of ABCG5 and ABCG8 Genes for Sitosterolemia in a Familial Hypercholesterolemia Cascade Screening Program	7
Whole-Transcriptome Profiling of Human Heart Tissues Reveals the Potential Novel Players and Regulatory Networks in Different Cardiomyopathy Subtypes of Heart Failure	7
Burden of Cardiomyopathic Genetic Variation in Lethal Pediatric Myocarditis	7
Prediction of Genotype Positivity in Patients With Hypertrophic Cardiomyopathy Using Machine Learning	7
Multiomic Profiling in Black and White Populations Reveals Novel Candidate Pathways in Left Ventricular Hypertrophy and Incident Heart Failure Specific to Black Adults	7
System Genetics Including Causal Inference Identify Immune Targets for Coronary Artery Disease and the Lifespan	7
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy	6
Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol Exposure	6
Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274	6
Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified TTN -Encoded Titin Truncating Variants	6
Risk of Congenital Heart Defects in Offspring of Affected Mothers and Fathers	6
Novel Missense Variant in MYL2 Gene Associated With Hypertrophic Cardiomyopathy Showing High Incidence of Restrictive Physiology	6
Epigenomic Profiles of African-American Transthyretin Val122Ile Carriers Reveals Putatively Dysregulated Amyloid Mechanisms	6
Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy	6
Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and Laminopathies	6
Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in Lamin A/C Cardiomyopathy	6
Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease	6

Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT	6
Genome-Wide Association Meta-Analysis Supports Genes Involved in Valve and Cardiac Development to Associate With Mitral Valve Prolapse	6
Genotype-Guided P2Y ₁₂ Inhibitor Therapy After Percutaneous Coronary Intervention: A Bayesian Analysis	6
Cardiocutaneous Features of Autosomal Dominant Desmoplakin-Associated Arrhythmogenic Cardiomyopathy	6
Recessive Inheritance of a Rare Variant in the Nuclear Mitochondrial Gene for AARS2 in Late-Onset Dilated Cardiomyopathy	6
South Asian–Specific MYBPC3 ^Δ25bp Intronic Deletion and Its Role in Cardiomyopathies and Heart Failure	6
Identification of Functional Genetic Determinants of Cardiac Troponin T and I in a Multiethnic Population and Causal Associations With Atrial Fibrillation	5
Genome-Wide Association Study for Idiopathic Ventricular Tachyarrhythmias Identifies Key Role of CCR7 and PKN2 in Calcium Homeostasis and	5
Human-Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for TNNT2 Δ160E-Induced Cardiomyopathy	5
Population Prevalence of Premature Truncating Variants in Plakophilin-2 and Association With Arrhythmogenic Right Ventricular Cardiomyopathy: A UK Biobank Analysis	5
Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1–Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome	5
Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study	5
Genome-Wide Association of Kidney Traits in Hispanics/Latinos Using Dense Imputed Whole-Genome Sequencing Data	5
Common Polymorphism That Protects From Cardiovascular Disease Increases Fibronectin Processing and Secretion	5
Truncating Variants in OBSCN Gene Associated With Disease-Onset and Outcomes of Hypertrophic Cardiomyopathy	5
Established Loss-of-Function Variants in ANK2 -Encoded Ankyrin-B Rarely Cause a Concerning Cardiac Phenotype in Humans	5
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization	5
Machine Learning to Understand Genetic and Clinical Factors Associated With the Pulse Waveform Dicrotic Notch	5
LZTR1 -Related Hypertrophic Cardiomyopathy Without Typical Noonan Syndrome Features	5
Associations of Genome-Wide Polygenic Risk Score and Risk Factors With Hypertension in a Japanese Population	5
Evidence-Based Assessment of Congenital Heart Disease Genes to Enable Returning Results in a Genomic Study	5
Life-Time Covariation of Major Cardiovascular Diseases	5
Clinical Conditions and Their Impact on Utility of Genetic Scores for Prediction of Acute Coronary Syndrome	4
CHDgene: A Curated Database for Congenital Heart Disease Genes	4
Role of Common Genetic Variation in Lone Atrial Fibrillation	4
Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women	4
Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment	4
Validation of Polygenic Risk Scores for Coronary Heart Disease in a Middle Eastern Cohort Using Whole Genome Sequencing	4
Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy	4
Multiethnic Genome-Wide Association Study of Subclinical Atherosclerosis in Individuals With Type 2 Diabetes	4
Susceptibility Locus for Pregnancy-Associated Spontaneous Coronary Artery Dissection	4
Familial Hypercholesterolemia in the Electronic Medical Records and Genomics Network: Prevalence, Penetrance, Cardiovascular Risk, and Outcomes After Return of Results	4
Fibromuscular Dysplasia and Abdominal Aortic Aneurysms Are Dimorphic Sex-Specific Diseases With Shared Complex Genetic Architecture	4
Genetic Dilated Cardiomyopathy Due to TTN Variants Without Known Familial Disease	4
MYH7 p.Glu903Gln Is a Pathogenic Variant Associated With Hypertrophic Cardiomyopathy	4
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib	4
Novel SCN5A Variant Shows Multiple Phenotypic Expression in the Same Family	4
Persistent Troponin Elevation in Left-Dominant Arrhythmogenic Cardiomyopathy	4
Functional Assays Reclassify Suspected Splice-Altering Variants of Uncertain Significance in Mendelian Channelopathies	4
Triadin Knockout Syndrome Is Absent in a Multi-Center Molecular Autopsy Cohort of Sudden Infant Death Syndrome and Sudden Unexplained Death in the Young and Is Extremely Rare in the General Population	4
Prevalence of Pathogenic Variants in Dilated Cardiomyopathy–Associated Genes in Patients Evaluated for Cardiac Sarcoidosis	4
Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus	4
Association of Genome-Wide Polygenic Risk Score for Body Mass Index With Cardiometabolic Health From Childhood Through Midlife	4
Influence of Panel Selection on Yield of Clinically Useful Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Families	4
Is There a Role for Genetic Testing in Patients With Myocarditis?	4
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin ( DSP ) Truncating Variant	4
Validation of a Polygenic Score for Beta-Blocker Survival Benefit in Patients With Heart Failure Using the United Kingdom Biobank	4
Prevalence and Phenotypic Burden of Monogenic Arrhythmias Using Integration of Electronic Health Records With Genetics	4
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines	4
Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction	4
Association of a Multiancestry Genome-Wide Blood Pressure Polygenic Risk Score With Adverse Cardiovascular Events	4
Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program	4
Proactive Variant Effect Mapping Aids Diagnosis in Pediatric Cardiac Arrest	4
Arrhythmogenic Right Ventricular Cardiomyopathy Prevalence and Arrhythmic Outcomes in At-Risk Family Members: A Systematic Review and Meta-Analysis	4
Left-Dominant Arrhythmogenic Cardiomyopathy, Palmoplantar Keratoderma, and Curly Hair Associated With a Rare Autosomal Dominant Truncating Variant in Desmoplakin	4